The efficacy of tyrosine kinase inhibitor dasatinib on colonic mucosal damage in murine model of colitis

Basit Öğe Kaydı
dc.contributor.authorCan, G.
dc.contributor.authorAyvaz, S.
dc.contributor.authorCan, H.
dc.contributor.authorKaraboga, I.
dc.contributor.authorDemirtas, S.
dc.contributor.authorAksit, H.
dc.contributor.authorYilmaz, B.
dc.date.accessioned2024-09-25T20:01:49Z
dc.date.available2024-09-25T20:01:49Z
dc.date.issued2016
dc.departmentAbant İzzet Baysal Üniversitesien_US
dc.identifier.endpageS127en_US
dc.identifier.issn1873-9946
dc.identifier.issn1876-4479
dc.identifier.startpageS126en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12491/14322
dc.identifier.volume10en_US
dc.identifier.wosWOS:000374496600198en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.institutionauthorKorkmaz, U.
dc.language.isoenen_US
dc.publisherOxford Univ Pressen_US
dc.relation.ispartofJournal of Crohns & Colitisen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzYK_20240925en_US
dc.titleThe efficacy of tyrosine kinase inhibitor dasatinib on colonic mucosal damage in murine model of colitisen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu